Close

Deutsche Bank Starts Prothena Corp (PRTA) at Buy

Go back to Deutsche Bank Starts Prothena Corp (PRTA) at Buy

Prothena Reports Third Quarter 2016 Financial Results and Provides R&D Update

November 1, 2016 4:05 PM EDT

Net cash used in operating and investing activities was $39.1 million in the third quarter and $96.8 million for the first nine months of 2016; quarter-end cash and restricted cash position of $412.6 million supports advancement of a diverse pipeline and commercial capabilitiesAppointed Gene G. Kinney, PhD President and Chief Executive Officer, following the passing of Prothena Co-founder, President and Chief Executive Officer Dale B. Schenk, PhDAnnounced strategy to advance a Phase 2 clinical trial for PRX003 in psoriatic arthritis

DUBLIN, Ireland, Nov.... More